| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Schimmel Paul serves as a Director at ATYR and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 33 buys and 5 sells. Those positions are worth an estimated $387K at current prices.
Historically, Schimmel Paul's trades have earned a middling insider score of 51/100 across 9 rated trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of +4.0%.
The biggest single holding is ATYR (~$387K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 2,912,114 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 164,411 | $0.74 | $121,573.38 | +31.1% | |
| May 18, 2018 | ATYR Atyr Pharma Inc | Director | Buy | 150,000 | $1.00 | $149,445.00 | +39.7% | |
| Mar 13, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | Director | Sale+OE | 27,823 | $150.00 | $4,173,450.00 | - | |
| Aug 31, 2017 | ATYR Atyr Pharma Inc | Director | Buy | 94,336 | $2.65 | $249,990.40 | +33.3% | |
| Apr 19, 2017 | FBRX Forte Biosciences, Inc. | Director | Buy | 10,000 | $10.00 | $100,000.00 | +276.0% | |
| Dec 21, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 25,000 | $2.28 | $56,928.00 | +3.6% | |
| Dec 16, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 50,000 | $2.48 | $123,885.00 | +7.7% | |
| Apr 14, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 66,219 | $4.18 | $276,933.57 | -501.4% | |
| Apr 13, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 9,835 | $3.85 | $37,864.75 | +4.1% | |
| Apr 12, 2016 | ATYR Atyr Pharma Inc | Director | Buy | 9,127 | $3.71 | $33,901.39 | +4.0% |